Researcher profile · Semantic Scholar

W. Lane

h-index: 12
Works: 23
Citations: 1,155

Most-cited papers

Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study
J. Buse, S. Garg, J. Rosenstock, T. Bailey +11 more
2018Diabetes Care216 citations Open access
Semantic Scholar
Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.
I. Hirsch, B. Bode, S. Garg, W. Lane +4 more
2005Diabetes Care190 citations Open access
Semantic Scholar
Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force.
G. Grunberger, Jill M. Abelseth, T. Bailey, B. Bode +7 more
2014Endocrine Practice173 citations
Semantic Scholar
Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial.
R. Tanenberg, B. Bode, W. Lane, C. Levetan +5 more
2004Mayo Clinic proceedings136 citations
Semantic Scholar
High-dose insulin therapy: is it time for U-500 insulin?
W. Lane, E. Cochran, J. A. Jackson, J. Scism-Bacon +3 more
2009Endocrine Practice113 citations
Semantic Scholar
The effect of addition of liraglutide to high‐dose intensive insulin therapy: a randomized prospective trial
W. Lane, S. Weinrib, J. Rappaport, C. Hale
2014Diabetes, obesity and metabolism82 citations
Semantic Scholar
The Effect of Liraglutide Added to U-500 Insulin in Patients with Type 2 Diabetes and High Insulin Requirements
W. Lane, S. Weinrib, J. Rappaport
2011Diabetes Technology & Therapeutics59 citations
Semantic Scholar
A prospective trial of U500 insulin delivered by Omnipod in patients with type 2 diabetes mellitus and severe insulin resistance.
W. Lane, S. Weinrib, J. Rappaport, Therese Przestrzelski
2010Endocrine Practice50 citations
Semantic Scholar
Use of U-500 regular insulin by continuous subcutaneous insulin infusion in patients with type 2 diabetes and severe insulin resistance.
W. Lane
2006Endocrine Practice48 citations
Semantic Scholar
The effect of long-term use of U-500 insulin via continuous subcutaneous infusion on durability of glycemic control and weight in obese, insulin-resistant patients with type 2 diabetes.
W. Lane, S. Weinrib, J. Rappaport, C. Hale +2 more
2013Endocrine Practice25 citations
Semantic Scholar
A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (ONSET 9)
W. Lane, E. Favaro, N. Rathor, H. Jang +7 more
2020Diabetes Care19 citations Open access
Semantic Scholar
Hypoglycemia with Mealtime Fast-Acting Insulin Aspart vs. Insulin Aspart Across Two Large Type 1 Diabetes Trials
C. D. De Block, Anders L. Carlson, L. Rose, T. Gondolf +2 more
2018Diabetes13 citations
Semantic Scholar
Glucose Variability and Time in Range in Type 2 Diabetes Treated with U-500R by Pump or Injection: CGM Findings from the VIVID Study
T. Blevins, W. Lane, D. Rodbard, D. Sindelar +5 more
2020Diabetes Technology & Therapeutics8 citations Open access
Semantic Scholar
Insulin degludec versus insulin glargine U100 for patients with type 1 or type 2 diabetes in the US: a budget impact analysis with rebate tables
W. Lane, J. Weatherall, J. Gundgaard, R. Pollock
2018Journal of Medical Economics7 citations Open access
Semantic Scholar
Comment on Feig et al. Pumps or Multiple Daily Injections in Pregnancy Involving Type 1 Diabetes: A Prespecified Analysis of the CONCEPTT Randomized Trial. Diabetes Care 2018;41:2471–2479
J. Sacha, W. Lane
2019Diabetes Care6 citations
Semantic Scholar
Basal Insulin degludec and GLycemic control ComparEd to Aspart via insulin Pump in type 1 diabetes (BIGLEAP): a single-center, open-label, randomized, crossover trial.
W. Lane, S. Weinrib, M. Lawrence, Benjamin Lane +1 more
2021Endocrine Practice4 citations
Semantic Scholar
AACE/ACE Consensus Statement
G. Grunberger, Jill M. Abelseth, T. Bailey, B. Bode +6 more
20142 citations
Semantic Scholar
Successful management of differentiated thyroid cancer in a community-based endocrine practice.
S. Weinrib, W. Lane, J. Rappaport
2012Endocrine Practice2 citations
Semantic Scholar
Effective Overall Glycaemic Control with Fast-Acting Insulin Aspart Across Patients with Different Baseline Characteristics: A Post Hoc Analysis of the Onset 9 Trial
W. Lane, E. Favaro, E. Jódar, P. Kelkar +5 more
2022Diabetes Therapy1 citations Open access
Semantic Scholar
ESICON 2017 Abstracts
M. Mengade, Babul Reddy, Jubin K. Kurian, Kishan Delampady +496 more
2017Indian journal of endocrinology and metabolism1 citations Open access
Semantic Scholar
1037-P: Efficacy and Safety of Fast-Acting Insulin Aspart in Adults with T2D with Different Insulin Requirements
W. Lane, M. Ekelund, Ólöf Thórisdóttir, E. Jódar +5 more
2020Diabetes0 citations
Semantic Scholar
1034-P: Efficacy and Safety of Fast-Acting Insulin Aspart According to Baseline HbA1c in Adults with Type 2 Diabetes Treated with a Basal-Bolus Regimen
E. Franek, M. Ekelund, Ólöf Thórisdóttir, H. Jang +6 more
2020Diabetes0 citations
Semantic Scholar
Häufigkeit von Hypoglykämien bei Patienten mit Typ 1 Diabetes in zwei großen Studien, in denen als Mahlzeiteninsulin entweder Faster aspart oder Insulin aspart verwendet wurde
T. Siegmund, C. D. De Block, Anders L. Carlson, L. Rose +2 more
2019Diabetologie und Stoffwechsel0 citations
Semantic Scholar

A. Oviedo

×4

L. Rose×4

E. Franek×4

W. Tamborlane×3

N. Rathor×3

G. Sesti×3

E. Jódar×3

J. Buse×2